High-impact journal Nature has published a paper featuring MaxWell Biosystems’ high-density microelectrode array technology, with which researchers identified a new potential therapeutic target against the rare and terminal disease ALS. The publication has the potential to significantly broaden and diversify the startup’s customer base.
